| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Tumor Biology |
Department of Biochemistry II, Nagoya University School of Medicine, Nagoya 466-0065 [S. Y., S. F., K. F.]; Department of Internal Medicine II, Nagoya City University School of Medicine, Nagoya 467-8601 [S. Y., H. K., S. S., R. U.]; and Department of Pediatric Dentistry, Nagasaki University School of Dentistry, Nagasaki 852-8102 [S. F.], Japan
Expression levels of gangliosides and glycosyltransferase genes responsible for their syntheses in human lung cancer cell lines and a normal bronchial epithelial cell line were analyzed. Both non-small cell lung cancers and small cell lung cancers (SCLCs) mainly expressed GM2 and GM1, whereas only SCLCs expressed b-series gangliosides, such as GD2, GD1b, and GT1b. Accordingly, many SCLC cell lines showed up-regulation of the GD3 synthase gene. Consequently, we introduced GD3 synthase cDNA into a SCLC line with low expression of b-series gangliosides and analyzed the effects of newly expressed gangliosides on tumor phenotypes. The transfectant cells expressing high levels of GD2 and GD3 exhibited markedly increased growth rates and strongly enhanced invasion activities. Addition of anti-GD2 monoclonal antibodies into the culture medium of these cells resulted in the marked growth suppression of GD2-expressing cell lines with reduced activation levels of mitogen-activated protein kinases but not of nonexpressants, suggesting that GD2 plays important roles in cell proliferation. Moreover, GD2-expressing cells treated with anti-GD2 antibodies showed features of apoptotic cell death at 30 min after addition of antibodies, i.e., shrinkage of cytoplasm, binding of Annexin V, and staining with propidium iodide, followed by DNA fragmentation. This GD2-mediated apoptosis was associated with caspase-3 activation and partly inhibited by a caspase inhibitor, z-Val-Ala-Asp-fluoromethyl ketone. The finding that anti-GD2 antibodies suppressed the cell growth and induced apoptosis of SCLC cells strongly suggested the usefulness of GD2 as a target for the therapy of disastrous cancer, although the precise mechanisms for apoptosis remain to be clarified.
This article has been cited by other articles:
![]() |
N. Alvarez-Rueda, S. Leprieur, B. Clemenceau, S. Supiot, V. Sebille-Rivain, A. Faivre-Chauvet, F. Davodeau, F. Paris, J. Barbet, J. Aubry, et al. Binding Activities and Antitumor Properties of a New Mouse/Human Chimeric Antibody Specific for GD2 Ganglioside Antigen Clin. Cancer Res., September 15, 2007; 13(18): 5613s - 5620s. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Raval, S. Biswas, P. Rayman, K. Biswas, G. Sa, S. Ghosh, M. Thornton, C. Hilston, T. Das, R. Bukowski, et al. TNF-{alpha} Induction of GM2 Expression on Renal Cell Carcinomas Promotes T Cell Dysfunction J. Immunol., May 15, 2007; 178(10): 6642 - 6652. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Tokuda, Q. Zhang, S. Yoshida, S. Kusunoki, T. Urano, K. Furukawa, and K. Furukawa Genetic mechanisms for the synthesis of fucosyl GM1 in small cell lung cancer cell lines Glycobiology, October 1, 2006; 16(10): 916 - 925. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. Crespo, X. Sun, J. G. Cripps, and R. Fernandez-Botran The immunoregulatory effects of gangliosides involve immune deviation favoring type-2 T cell responses J. Leukoc. Biol., March 1, 2006; 79(3): 586 - 595. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Aixinjueluo, K. Furukawa, Q. Zhang, K. Hamamura, N. Tokuda, S. Yoshida, R. Ueda, and K. Furukawa Mechanisms for the Apoptosis of Small Cell Lung Cancer Cells Induced by Anti-GD2 Monoclonal Antibodies: ROLES OF ANOIKIS J. Biol. Chem., August 19, 2005; 280(33): 29828 - 29836. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hamamura, K. Furukawa, T. Hayashi, T. Hattori, J. Nakano, H. Nakashima, T. Okuda, H. Mizutani, H. Hattori, M. Ueda, et al. Ganglioside GD3 promotes cell growth and invasion through p130Cas and paxillin in malignant melanoma cells PNAS, August 2, 2005; 102(31): 11041 - 11046. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Retter, J. C. Johnson, D. W. Peckham, J. E. Bannink, C. S. Bangur, K. Dresser, F. Cai, T. M. Foy, N. A. Fanger, G. R. Fanger, et al. Characterization of a Proapoptotic Antiganglioside GM2 Monoclonal Antibody and Evaluation of Its Therapeutic Effect on Melanoma and Small Cell Lung Carcinoma Xenografts Cancer Res., July 15, 2005; 65(14): 6425 - 6434. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Monzavi-Karbassi, C. Artaud, F. Jousheghany, L. Hennings, J. Carcel-Trullols, S. Shaaf, S. Korourian, and T. Kieber-Emmons Reduction of Spontaneous Metastases through Induction of Carbohydrate Cross-Reactive Apoptotic Antibodies J. Immunol., June 1, 2005; 174(11): 7057 - 7065. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhang and F. L. Kiechle Glycosphingolipids in Health and Disease Ann. Clin. Lab. Sci., January 1, 2004; 34(1): 3 - 13. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-Q. Wang, P. Sun, and A. S. Paller Inhibition of Integrin-linked Kinase/Protein Kinase B/Akt Signaling. MECHANISM FOR GANGLIOSIDE-INDUCED APOPTOSIS J. Biol. Chem., November 21, 2001; 276(48): 44504 - 44511. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |